Autumn Glory Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 | +$6.15M | |
| 2 | +$4.29M | |
| 3 | +$4.15M | |
| 4 |
NVIDIA
NVDA
|
+$4.07M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$3.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 | +$2.38M | |
| 2 | +$1.09M | |
| 3 | +$1.06M | |
| 4 |
SPDR Gold Trust
GLD
|
+$817K |
| 5 |
Dorchester Minerals
DMLP
|
+$709K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.13% |
| 2 | Energy | 7.78% |
| 3 | Healthcare | 7.09% |
| 4 | Industrials | 6.33% |
| 5 | Financials | 6.26% |
Similar funds
Autumn Glory Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Autumn Glory Partners held 229 positions worth $353M, up 30% from $272M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Autumn Glory Partners deployed $58.3M of net new capital in Q2 2026, opening 25 new positions and adding to 80 existing holdings. Its largest new stake was Novo Nordisk: 99,888 shares worth $4.79M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 6.3% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was JPMorgan Equity Premium Income ETF, an estimated $1.06M trimmed.
- Autumn Glory Partners's largest Q2 2026 buy was Novo Nordisk: 99,888 shares worth $4.79M.
- Autumn Glory Partners added most to Alphabet (Google) Class A in Q2 2026, an estimated $6.15M increase.
- Autumn Glory Partners's biggest Q2 2026 reduction was JPMorgan Equity Premium Income ETF, cutting an estimated $1.06M.
- Autumn Glory Partners fully exited Vanguard Short-Term Treasury ETF in Q2 2026, selling an estimated $2.38M.
- Autumn Glory Partners's ten largest holdings make up 31% of its $353M portfolio in Q2 2026.
- Autumn Glory Partners opened 25 new positions and closed 17 in Q2 2026.
- Autumn Glory Partners's portfolio value rose 30% quarter-over-quarter to $353M.
Based on Autumn Glory Partners's 13F filing for Q2 2026, filed 3 Aug 2026.